Targeting Tumor Cells with Nanoparticles for Enhanced Co-Drug Delivery in Cancer Treatment

Gastric cancer (GC) is a fatal malignant tumor, and effective therapies to attenuate its progression are lacking. Nanoparticle (NP)-based solutions may enable the design of novel treatments to eliminate GC. Refined, receptor-targetable NPs can selectively target cancer cells and improve the cellular...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Wen-Ying, Lai, Chih-Ho, Peng, Shin-Lei, Hsu, Che-Yu, Hsu, Po-Hung, Chu, Pei-Yi, Feng, Chun-Lung, Lin, Yu-Hsin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465501/
https://www.ncbi.nlm.nih.gov/pubmed/34575403
http://dx.doi.org/10.3390/pharmaceutics13091327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465501/
https://www.ncbi.nlm.nih.gov/pubmed/34575403
http://dx.doi.org/10.3390/pharmaceutics13091327

Ejemplares similares